Celltrion Inc. v. Genentech, Inc. > Summary
Court Case Number IPR2017-01227
Filing Date Mar 31, 2017
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesSheridan K. Snedden, Erica A. Franklin, Jacqueline T. Harlow
Judge Writing the Final DecisionSheridan K. Snedden
Claims Challenged in the Petition: 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
Petitioner
Patent Owner
Petitioner Attorneys
6Celltrion
Attorney Name: Susan Krumplitsch
Cooley LLP
Celltrion
Attorney Name: Adam Pivovar
Cooley LLP
Celltrion
Attorney Name: James P. Brogan
Cooley LLP
Celltrion
Attorney Name: Michelle S. Rhyu
Cooley LLP
Celltrion
Attorney Name: Lauren J. Strosnick
Cooley LLP
Celltrion
Attorney Name: Maria Weiand
Cooley LLP
Patent Owner Attorneys
7Genentech, Inc
Attorney Name: Lauren N. Drake
Irell & Manella LLP
Genentech, Inc
Attorney Name: David I. Gindler
Irell & Manella LLP
Genentech, Inc
Attorney Name: Yite John Lu
Irell & Manella LLP
Genentech, Inc
Attorney Name: Keith A. Orso
Irell & Manella LLP
Genentech, Inc
Attorney Name: Gary N. Frischling
Irell & Manella LLP
Genentech, Inc
Attorney Name: Michael R. Fleming
Irell & Manella LLP
Genentech, Inc
Attorney Name: David P. Schenkein
Genentech, Inc
Related Patents
Doc No | Title | Issue date |
---|---|---|
07682612 | Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody | Mar 23, 2010 |